Class information for:
Level 1: ESTROGENIC RECRUITMENT//AMINOGLUTETHIMIDE//CYCLIC TREATMENT

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
13067 798 29.0 44%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
232 19686 TAMOXIFEN//AROMATASE INHIBITORS//ANASTROZOLE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ESTROGENIC RECRUITMENT Author keyword 3 100% 0% 3
2 AMINOGLUTETHIMIDE Author keyword 2 14% 1% 11
3 CYCLIC TREATMENT Author keyword 1 33% 0% 2
4 COMBINED ENDOCRINE TREATMENT Author keyword 1 50% 0% 1
5 DMBA INDUCED RAT MAMMARY CARCINOMA Author keyword 1 50% 0% 1
6 DOXORUBICIN UPTAKE Author keyword 1 50% 0% 1
7 DRUG TO DRUG INTERACTION Author keyword 1 50% 0% 1
8 ENDOCRINE METAB DRUG PROD Address 1 50% 0% 1
9 FUNKT BEREICH PSYCHOSOMAT FRAUENHEILKUNDE Address 1 50% 0% 1
10 GAMMA CYCLODEXTRIN COMPLEX Author keyword 1 50% 0% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ESTROGENIC RECRUITMENT 3 100% 0% 3 Search ESTROGENIC+RECRUITMENT Search ESTROGENIC+RECRUITMENT
2 AMINOGLUTETHIMIDE 2 14% 1% 11 Search AMINOGLUTETHIMIDE Search AMINOGLUTETHIMIDE
3 CYCLIC TREATMENT 1 33% 0% 2 Search CYCLIC+TREATMENT Search CYCLIC+TREATMENT
4 COMBINED ENDOCRINE TREATMENT 1 50% 0% 1 Search COMBINED+ENDOCRINE+TREATMENT Search COMBINED+ENDOCRINE+TREATMENT
5 DMBA INDUCED RAT MAMMARY CARCINOMA 1 50% 0% 1 Search DMBA+INDUCED+RAT+MAMMARY+CARCINOMA Search DMBA+INDUCED+RAT+MAMMARY+CARCINOMA
6 DOXORUBICIN UPTAKE 1 50% 0% 1 Search DOXORUBICIN+UPTAKE Search DOXORUBICIN+UPTAKE
7 DRUG TO DRUG INTERACTION 1 50% 0% 1 Search DRUG+TO+DRUG+INTERACTION Search DRUG+TO+DRUG+INTERACTION
8 GAMMA CYCLODEXTRIN COMPLEX 1 50% 0% 1 Search GAMMA+CYCLODEXTRIN+COMPLEX Search GAMMA+CYCLODEXTRIN+COMPLEX
9 GENE PROFILE EXPRESSION 1 50% 0% 1 Search GENE+PROFILE+EXPRESSION Search GENE+PROFILE+EXPRESSION
10 TUMOUR FLARE 1 50% 0% 1 Search TUMOUR+FLARE Search TUMOUR+FLARE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 V TAMOXIFEN 11 100% 1% 6
2 PIEDMONT ONCOLOGY ASSOCIATION 6 41% 1% 11
3 DOSE MEDROXYPROGESTERONE ACETATE 6 31% 2% 15
4 PLUS HYDROCORTISONE 4 67% 1% 4
5 ESTROGENIC RECRUITMENT 3 42% 1% 5
6 COMPARING AMINOGLUTETHIMIDE 2 67% 0% 2
7 LOW DOSE AMINOGLUTETHIMIDE 2 26% 1% 7
8 PRIMARY ENDOCRINE TREATMENT 2 40% 1% 4
9 ACETATE V TAMOXIFEN 1 50% 0% 1
10 AMINOGLUTETHIMIDE THERAPY 1 50% 0% 1

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
ENDOCRINE TREATMENT OF BREAST-CANCER IN WOMEN 1990 315 203 42%
Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer 2000 98 65 40%
FIRST GENERATION AROMATASE INHIBITORS - AMINOGLUTETHIMIDE AND TESTOLOLACTONE 1994 39 56 75%
Tamoxifen ('Nolvadex'): a review 2002 93 91 20%
TAMOXIFEN IN THE TREATMENT OF BREAST-CANCER 1988 84 51 57%
MECHANISMS OF ACTION OF AMINOGLUTETHIMIDE AS ENDOCRINE THERAPY OF BREAST-CANCER 1988 61 91 68%
DOSE-RESPONSE EVALUATION - USE OF PLASMA-CONCENTRATION CONFIDENCE-INTERVALS AS A TOOL TO PREDICT OPTIMAL DRUG DOSE RATIO 1993 5 6 100%
Hormonal therapy of breast cancer 1998 36 209 16%
Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy 2008 24 52 19%
Additive endocrine therapy for advanced breast cancer - back to the future 2009 15 58 26%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 ENDOCRINE METAB DRUG PROD 1 50% 0.1% 1
2 FUNKT BEREICH PSYCHOSOMAT FRAUENHEILKUNDE 1 50% 0.1% 1
3 HAUKELAND HOSP MED 1 50% 0.1% 1
4 HAUKELAND HOSP ONCOL 1 50% 0.1% 1
5 MECHANISMS DRUG TOXIC GRP 1 50% 0.1% 1
6 MED 2 13 GARNISONGASSE 1 50% 0.1% 1
7 SPECIALIZED CANC 1 50% 0.1% 1
8 COUNSELLING TRAINING GRP 0 33% 0.1% 1
9 IST ONCOL SPERIMENTALE CLIN 0 33% 0.1% 1
10 NAT SCI MATH ENVIRONM 0 33% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000189436 AROMATASE INHIBITORS//EXEMESTANE//ANASTROZOLE
2 0.0000140667 19 OXYGENATION//HUMAN PLACENTAL MICROSOME//HUMAN PLACENTAL MICROSOMES
3 0.0000133525 TAMOXIFEN//TOREMIFENE//DROLOXIFENE
4 0.0000132614 HIGH DOSE CHEMOTHERAPY//DOSE INTENSITY//HIGH RISK BREAST CANCER
5 0.0000099895 AEBS//ANTIESTROGEN BINDING SITES//ANALOG II
6 0.0000094847 MOLECULAR APOCRINE//DAME ROMA MITCHELL CANC S//ESTROGEN RECEPTOR NEGATIVE
7 0.0000090549 ER ICA//IMMUNOCYTOCHEMICAL ASSAY//PROGESTERONE RECEPTORS
8 0.0000090087 ENDOXIFEN//DESMETHYLTAMOXIFEN//N DESMETHYL TAMOXIFEN
9 0.0000083065 INTIMA TO MEDIA RATIO//EPIDEMIOL HLTH BEHAV SOC//BIOL DOSE SECT
10 0.0000077766 SUBJEFATURA INVEST BIOMED//UNIDAD INVEST MED BIOL REPROD//COLPOSCOPIA